While detailed descriptions of the variables that can be customized in QuPath are available from its developers, the literature is lacking a simple step-wise protocol for the development and implementation of QuPath PD-L1 scoring in NSCLC. This evidence concerns the gene CD274 and non-small cell lung carcinoma.